ANXA1 was increased in CD8 memory T cell post-treatment, which has been reported to inhibit the anti-tumor immunity and support the formation of an immunosuppressed tumor microenvironment that promotes tumor growth and metastasis [31]. The gene discussed is ANXA1; the disease is neoplasm.